EP
AMED

Edgestream Partners’s Amedisys AMED Stock Holding History

Edgestream Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,975
Closed -$1.28M – 856
2025
Q2 		$1.28M Buy
12,975
+8,525
+192% +$807K 0.04% 604
2025
Q1 		$412K Buy
+4,450
New +$410K 0.01% 723
2024
Q4 		– Sell
-48,347
Closed -$4.67M – 847
2024
Q3 		$4.67M Buy
+48,347
New +$4.72M 0.21% 148
2024
Q2 		– Sell
-49,482
Closed -$4.56M – 828
2024
Q1 		$4.56M Sell
49,482
-11,154
-18% -$1.05M 0.23% 134
2023
Q4 		$5.76M Buy
+60,636
New +$5.66M 0.41% 14
2022
Q1 		– Sell
-2,265
Closed -$367K – 527
2021
Q4 		$367K Buy
+2,265
New +$364K 0.02% 419

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Edgestream Partners's AMED Position: Q3 2025 in Review

Edgestream Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 12,975 shares — an estimated $1.28M sold.

Edgestream Partners first reported a position in AMED in Q4 2021 and held it in 6 quarters. The position peaked at $5.76M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Edgestream Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Edgestream Partners sold 12,975 Amedisys shares in Q3 2025, an estimated $1.28M.
  • Edgestream Partners first reported a position in Amedisys in Q4 2021 and held it in 6 quarters.
  • Edgestream Partners's Amedisys position peaked at $5.76M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Edgestream Partners's 13F filing for Q3 2025, filed 12 Nov 2025.